Skip to main content
Clinical Trials/ISRCTN39154605
ISRCTN39154605Completed未知

A pragmatic randomised controlled trial of response to an invitation to self-sampling for human papillomavirus (HPV) versus repeat invitation for cervical screening in persistent non-responders in Newcastle upon Tyne

Queen Mary University of London (UK)0 sites300 target enrollmentStarted: October 4, 2012Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
300

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • Non-responders according to the North East Primary Care Services Agency (NEPCSA) recall process. They will have received their initial screening letter, plus a first reminder letter, plus at least two non-responder cards will have been sent to their General Practitioner, identified using the NEPCSA Exeter National Health Applications and Infrastructure Services (NHAISs) System.

Exclusion Criteria

  • 1. Women who have written to the NEPCSA to document their refusal to take part in the NHSCSP
  • 2. Women who contact the trial team and ask to be excluded from the trial
  • 3. Pregnancy
  • 4. Total abdominal hysterectomy
  • 5. Never been sexually active
  • 6. Women who are identified as becoming pregnant or undergoing hysterectomy following the initial test will be excluded from the analysis of data for secondary outcomes
  • 7. HPV self-sample returned without a signed Informed Consent Form (ICF) (the Participant Information Leaflet (PIL) will state that samples returned without a signed consent form cannot be processed)
  • 8. Informed Consent Form (ICF) returned with incomplete contact details whereby the test results cannot be sent

Investigators

Sponsor
Queen Mary University of London (UK)

Similar Trials